author-photo

Danielle Glassman

New York Medical College

1

Papers

1

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Obinutuzumab (GA101) Significantly Enhances Cell Death and ADCC Compared to Rituximab Against CD20+ sensitive and Rituximab Resistant B-Cell Non-Hodgkin Lymphoma (NHL) and Lymphoblastic Leukemia (BLL)

2012 Blood
Show All
- Source
- Cite
- Save
Citations (1)